DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Antagomir
Antagomir
Microrna-33A Regulates Cholesterol Synthesis and Cholesterol Efflux
Antagomirs’
Ablation of Mir-144 Increases Vimentin Expression and Atherosclerotic Plaque Formation Quan He1, Fangfei Wang1, Takashi Honda1, Kenneth D
Cancer Stem Cells in Pancreatic Cancer
Development of Novel Therapeutic Agents by Inhibition of Oncogenic Micrornas
The Positive Effect of Mir1 Antagomir on Ischemic Neurological Disorders Via Changing the Expression of Bcl-W and Bad Genes
Microrna21 Contributes to Myocardial Disease by Stimulating MAP Kinase
Microrna Regulation of Human Pancreatic Cancer Stem Cells
Mir-122 in Hepatic Function and Liver Diseases
Therapeutic Evaluation of Micrornas by Molecular Imaging Thillai V
Charakterisierung Der Funktionellen Bedeutung Der Mikrorna-34A Während Der Entwicklung Und Der Tumorgenese Mittels Eines Mausmodells
Microrna Therapeutics
Systemic Delivery of Microrna As a Therapeutic Modality to Treat Cancer
Circulating Microrna-122 Is Associated with the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes
Reciprocal Effects of Mir-122 on Expression of Heme Oxygenase-1
Silencing of Microrna-135B Inhibits Invasion
Liver Microrna-21 Is Overexpressed in Non-Alcoholic Steatohepatitis And
Stabilization of Hepatitis C Virus RNA by an Ago2–Mir-122 Complex
Top View
RNA-Based Therapeutics: from Antisense Oligonucleotides to Mirnas
Highly Potent Galnac-Conjugated Tiny LNA Anti-Mirna-122 Antisense Oligonucleotides
Mir-21 Antagomir Improves Insulin Resistance and Lipid Metabolism Disorder in Streptozotocin-Induced Type 2 Diabetes Mellitus Rats
Microrna-100 Suppresses Chronic Vascular Inflammation by Stimulation of Endothelial Autophagy
Mir-33A Is Up-Regulated in Chemoresistant Osteosarcoma And
Participation of Micrornas in the Treatment of Cancer with Phytochemicals
Microrna-27A Controls the Intracellular Survival of Mycobacterium Tuberculosis by Regulating Calcium- Associated Autophagy
Osteoblast-Targeted Delivery of Mir-33-5P Attenuates Osteopenia
Original Article Downregulation of Mir-93 Elevates Nrf2 Expression and Alleviates Reactive Oxygen Species and Cell Apoptosis in Diabetic Retinopathy
Microrna-301A Regulation of a T-Helper 17 Immune Response
Chemical Modification of Nucleic Acids As a Key Technology for The
Micrornas, Hepatitis C Virus, and HCV/HIV-1 Co-Infection: New Insights in Pathogenesis and Therapy
Hur-Dependent Loading of Mirna RISC to the Mrna Encoding the Ras-Related Small Gtpase Rhob Controls Its Translation During UV-Induced Apoptosis
Targeting Micrornas in Pancreatic Cancer: Microplayers in the Big Game
Identification of Microrna-27A As a Key Regulator of Cholesterol Homeostasis
Multifunctional RNA Nanoparticles for TNBC Treatment
Muscle Stem Cell Behavior Is Modified by Microrna-27 Regulation of Pax3 Expression
Effect of LXR Agonist T0901317 and Mir-33Inhibitor on SIRT1-AMPK and Circulating HDL-C Levels A
Foam Cells As Therapeutic Targets in Atherosclerosis with a Focus on the Regulatory Roles of Non-Coding Rnas
Loss of Mir-122 Expression in Liver Cancer Correlates with Suppression of the Hepatic Phenotype and Gain of Metastatic Properties
Microrna-144 Silencing Protects Against Atherosclerosis in Male, but Not Female Mice
RNA-Binding Protein Hur Sequesters Microrna-21 to Prevent Translation Repression of Proinflammatory Tumor Suppressor Gene Programmed Cell Death 4
Aus Der Medizinischen Klinik Und Poliklinik IV Der Ludwig-Maximilians-Universität München Arbeitsgruppe Klinische Biochemie Vorstand: (Direktor: Prof
How Close Are Mirnas from Clinical Practice?
Targeted Antagomir Delivery to Sequester Oncogenic Mir-221 in HCC